1)- Waldemar Misiorowski, Marek Dedecjus, Jerzy Konstantynowicz, Arkadiusz Zygmunt, Beata Kos-Kudła, Andrzej Lewiński, Marek Ruchała, Wojciech Zgliczyński. Management of hypoparathyroidism: a Position Statement of the Expert Group of the Polish Society of Endocrinology.Endokrynologia Polska. 2023, 74 (5): 447-467
5)- Jerzy Przedlacki, Urszula Ołdakowska-Jedynak. The antifracture efficacy of vitamin D in adults - are we assessing it reliably? A systematic review.Endokrynologia Polska. 2023, 74 (5): 499-510
7)- Kui Yao, Heng Zheng, Hongling Peng. Association between polycystic ovary syndrome and risk of non-alcoholic fatty liver disease: a meta-analysis.Endokrynologia Polska. 2023, 74 (5): 520-527
9)- Min Li, Meimei Tian, Yuling Wang, Huijie Ma, Yaru Zhou, Xinli Jiang, Yan Liu. Association of plasma galectin-3 and fetuin-A levels with diabetic retinopathy in type 2 diabetes mellitus patients.Endokrynologia Polska. 2023, 74 (5): 536-543
13)- Michał Senger, Tomasz Andrzej Dziedzic, Magdalena Góralska, Tomasz Gotlib, Przemysław Kunert. Delayed symptomatic cerebral vasospasm after transsphenoidal resection of pituitary adenoma.Endokrynologia Polska. 2023, 74 (5): 561-562
15)- Agata Czarnywojtek, Magdalena Borowska, Kamil Dyrka, Jakub Moskal, Jeremi Kościński, Iwona Krela-Kaźmierczak, Agnieszka Marta Lewandowska, Boushra Abou Hjeily, Paweł Gut, Karolina Hoffmann, Stefaan Van Gool, Nadia Sawicka-Gutaj, Marek Ruchała. The influence of various endocrine disruptors on the reproductive system.Endokrynologia Polska. 2023, 74 (3): 221-233
17)- Ewa Marcinowska-Suchowierska, Tomasz Blicharski, Ewa Wielosz, Maria Rell-Bakalarska, Krzysztof Duma, Katarzyna Paradowska-Kowal, Ewa Sewerynek. Osteoporosis treatment with denosumab in routine clinical practice in Poland.Endokrynologia Polska. 2023, 74 (3): 243-253
18)- Xueqin Yan, Guomei Jiang, Chunhui Yang, Yuming Chen, Jie Zeng, Lianhong Huang, Xia Chen, Jialuo Liao. The impact of subclinical hypothyroidism on growth and development in infants and young children aged 0 to 5 years.Endokrynologia Polska. 2023, 74 (3): 254-259
19)- Weiming Wu, Shujie Li, Ke Xu, Zhaowei Meng. Hazard ratios of second primary malignancy after radioiodine for differentiated thyroid carcinoma: a large-cohort retrospective study.Endokrynologia Polska. 2023, 74 (3): 260-270
22)- Anna Świąder-Leśniak, Dorota Jurkiewicz, Honorata Kołodziejczyk, Agata Kozłowska, Alicja Korpysz, Mieczysław Szalecki, Krystyna Chrzanowska. The effects of 3-year growth hormone treatment and body composition in Polish patients with Silver-Russell syndrome.Endokrynologia Polska. 2023, 74 (3): 285-293
23)- Bingqing Xu, Ruohuang Wang, Jisheng Zhang, Lin Wang, Xin Cui, Fangyu Chai, Xiaoyun Du, Yan Jiang. Bioinformatics analysis of CUL2/4A/9 and its function in head and neck squamous cell carcinoma.Endokrynologia Polska. 2023, 74 (3): 315-330
24)- Wojciech S Zgliczyński, Adam Skowron. Demographics, practice patterns, job satisfaction, and career plans of endocrinologists in Poland.Endokrynologia Polska. 2023, 74 (3): 331-339
25)- Anna Bogusławska, Mari Minasyan, Alicja Hubalewska-Dydejczyk, Aleksandra Gilis-Januszewska. COVID-19 infection in a patient with Cushing's disease on osilodrostat treatment.Endokrynologia Polska. 2023, 74 (3): 342-343
26)- Bartłomiej Borawski, Agnieszka Wojciechowska-Luźniak, Grzegorz Zieliński, Przemysław Witek. Progression of a corticotroph tumour during durable medical therapy with osilodrostat in a patient with persistent Cushing's disease.Endokrynologia Polska. 2023, 74 (3): 346-347
31)- Francesca Bambini, Elisa Gatta, Rossella D'Alessio, Francesco Dondi, Giusto Pignata, Ilenia Pirola, Francesco Bertaga, Carlo Cappelli. Thyroid disease and autoimmunity in obese patients: a narrative review.Endokrynologia Polska. 2023, :
32)- Xiaoke Zheng, Lichang Zhong, Tianjiao Zhou, Feng Zhao, Bin Chen. Association between TSH suppression therapy and type 2 deiodinase gene polymorphism in differentiated thyroid carcinoma.Endokrynologia Polska. 2023, :
33)- Marta Opalińska, Aleksandra Gilis-Januszewska, Karolina Morawiec-Sławek, Anna Kurzyńska, Anna Sowa-Staszczak, Anna Bogusławska, Ewelina Rzepka, Alicja Hubalewska-Dydejczyk. Differences in clinical characteristics, treatment, and outcomes of sporadic and MEN-1-related insulinomas.Endokrynologia Polska. 2023, :
34)- Diana Nabrdalik-Leśniak, Katarzyna Nabrdalik, Krzysztof Irlik, Oliwia Janota, Hanna Kwiendacz, Paulina Szromek-Białek, Mirosław Maziarz, Tomasz Stompór, Janusz Gumprecht, Gregory Y H Lip. The influence of SGLT2 inhibitors on oxidative stress in heart failure and chronic kidney disease in patients with type 2 diabetes.Endokrynologia Polska. 2023, :
35)- Grzegorz Erbert, Elżbieta Łomna-Bogdanov, Marek Bolanowski. Diagnostic and therapeutic difficulties in a patient with corticotropic pituitary macroadenoma.Endokrynologia Polska. 2023, :
37)- Wojciech Pluskiewicz, Piotr Adamczyk, Bogna Drozdzowska. Functional status as a predictor of the incidence of falls in 10-year follow-up: results from the RAC-OST-POL study.Endokrynologia Polska. 2023, :
38)- Enver Avcı, Mine Ozturk. Evaluation of neutrophil HDL-C ratio - a new inflammation marker in non-alcoholic fatty liver disease.Endokrynologia Polska. 2023, :
40)- Süleyman Sönmez, Elif Önder, Mehtap Navdar Başaran, Hatice Çalışkan, Yıldıray Topçu, Sevcan Genç, Hande Peynirci. A comparison of the 2 thermal ablation procedures for the management of benign thyroid nodules.Endokrynologia Polska. 2023, :
41)- Xiaomei Meng, Xiao Yu, Peipei Lei. Clinical value of miR-23a-3p expression in early diagnosis of diabetic kidney disease.Endokrynologia Polska. 2023, :
43)- Fan Xiong, Qian Wang, Yun Hu, Xiao Jiang, Lin Liu, Yumeng Han, Qing Jiang, Shiqin Yuan, Lan Xu. Ultrasound characteristics of the cervical vagus nerve in patients with type 2 diabetes and diabetic peripheral neuropathy.Endokrynologia Polska. 2023, :
44)- Wojciech Pluskiewicz. Comments on "Guidelines for the diagnosis and management of osteoporosis in Poland. Update 2022".Endokrynologia Polska. 2023, :
45)- Mateusz Maligłówka, Aleksandra Sojka, Anna Bartecka, Łukasz Bułdak, Bogusław Okopien. Lethargic patient with hepatocirrhosis - more than meets the eye.Endokrynologia Polska. 2023, :
46)- Adam Daniel Durma, Marek Saracyn, Anna Celina Durma, Grzegorz Kamiński. Difficulties in achieving euthyroid status in a patient with differentiated thyroid cancer after sleeve gastrectomy.Endokrynologia Polska. 2023, :
47)- Renata Stawerska, Paula Smalczewska, Anna Łupińska, Katarzyna Wojciechowska-Durczyńska, Wojciech Stawerski, Maciej Hilczer, Grzegorz Zieliński, Adam Durczyński, Andrzej Lewiński. GH-secreting pituitary adenoma in the course of McCune‑Albright syndrome in a 21-year-old patient complicated by hepatocellular carcinoma.Endokrynologia Polska. 2023, :
48)- Dominik Porada, Jakub Gołacki, Beata Matyjaszek-Matuszek. Obesity in perimenopause - current treatment options based on pathogenetic factors.Endokrynologia Polska. 2023, :
49)- Magdalena Szychlińska, Magdalena Rzeczkowska, Wojciech Matuszewski, Elżbieta Bandurska-Stankiewicz. Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and 10-year cardiovascular mortality based on the SCORE algorithm? A study from a single centre in Poland.Endokrynologia Polska. 2023, :